Why Analysts Are Chasing Broadcom So Much Higher
When Broadcom reported its most recent quarterly results on Thursday, revenues and earnings beat expectations, but this was not enough for investors.
All Work
Chris Lange
What Analysts Are Saying About Salesforce After Earnings
Salesforce.com's share price drooped. This was not necessarily based on the latest quarterly numbers, but really it was the near-term guidance that failed to impress.
5 Companies That Destroyed Shareholders Last Week
Even though the market has made incredible gains, a few companies held it back from pushing even higher, including SolarCity and Tesla Motors.
Smith & Wesson Earnings Fail to Impress Investors
Smith & Wesson beat on the top and bottom lines, practically doubling its earnings year over year, but this was not enough for investors.
Why Merrill Lynch Sees So Much Downside to Lululemon
After Lululemon Athletica reported inline fiscal second-quarter earnings results, Merrill Lynch analysts were not impressed.
Ambarella Earnings Not Enough for Investors
Ambarella reported its fiscal second-quarter financial results after the markets closed on Thursday and shares fell sharply Friday morning.
8 Major FDA Decisions and Trial Results to Watch for in September
24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.
Why Boston Scientific Shares Could Rise Almost 40% More as Turnaround Continues
If the independent research firm Argus is correct, then Boston Scientific shareholders could see an upside of roughly 40% from the current price level.
What to Look for in Broadcom Earnings
Broadcom is scheduled to release its fiscal third-quarter financial results after the markets close on Thursday.
How Analysts Rate Salesforce After Earnings
Investors sent shares tumbling after Salesforce.com posted earnings, but analysts took a fairly positive position after the report.
Is Sunovion Overpaying for Cynapsus?
Shares of Cynapsus Therapeutics more than doubled on Thursday after it was announced that Sunovion Pharmaceuticals would be acquiring the company.
What to Expect From Lululemon Earnings
Other major retailers and brand name clothiers that have reported recently have either won big or lost big, and considering the tailwinds that Lululemon has had this year, it might be in store for…
Why Salesforce Earnings Were Not Enough for Investors
Salesforce.com, Inc. (NYSE: CRM) reported fiscal second-quarter financial results after the markets closed on Wednesday. Looking at this quarter’s numbers, most would think that investors would be content, but this is not the case.…
Why Under Armour May Not Be Growing Fast Enough
Although Argus expects Under Armour to post strong revenue going forward, the firm thinks that further expansion of the business will require substantial investment.
Have Analysts Cut Abercrombie & Fitch Ratings Too Much?
When Abercrombie & Fitch reported second-quarter fiscal 2016 results on Tuesday, the retailer posted another net loss and investors were not pleased, sending the stock down about 20%.
When 2 Pawn Giants Become 1
Shares of First Cash Financial Services and Cash America International were dragging their feet on Wednesday after the companies announced the shareholder approval of their merger.
What Look for in Ambarella Earnings
Considering GoPro's most recent earnings were mixed, it might be a tough call to say where Ambarella is going, but investors were fairly positive at the time for GoPro.
How H&R Block’s Cost Reduction Plan Backfired
Over the course of the fiscal first quarter, H&R Block was looking to reduce costs across the board with changes in its capital structure, but seemingly this backfired.
SINA Gears Up for Weibo Distribution
SINA watched its shares slide on Wednesday following the announcement that the company will be distributing part of its stake in its majority-owned subsidiary Weibo.
What Analysts Are Saying About Palo Alto Networks After Earnings
Palo Alto Networks posted relatively solid results for its fiscal fourth-quarter. However, the win in this quarter did not balance out the weaker guidance for the coming quarter.